An underground economy for unapproved slimming drugs is propelled by social media fitness personalities and sellers on messaging platforms, according to new investigations.
Investigational Drug Acquiring Popularity Online
The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its alleged fat-burning properties. Followers are urged to message these accounts privately for source information, while also obtaining promotional offers.
Thriving Commerce on Messaging Platforms
Additionally, a robust market exists on Telegram, where communities with numerous of members share comparison images, administration instructions and claims of next-day UK delivery. Vendors market the drug there before directing customers to other platforms for transactions.
Understanding Retatrutide
Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could assist individuals reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the next Ozempic.
Medical Experts Voice Worries
However, doctors and pharmacists have cautions that the distribution of what remains an unapproved medication in the United Kingdom is a cause for concern and could result in users administering products of uncertain source.
Several professionals said the popularity for the experimental drug could be connected to the increasing price of approved weight loss treatments such as Mounjaro.
Legal Status and Enforcement
Marketing retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unapproved medication that cannot be marketed or supplied for human use under the Human Medicines Regulations 2012.
Some influencers try to sidestep the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still violate pharmaceutical, marketing, and consumer regulations, potentially leading to penalties, legal action or imprisonment.
Platform Response and Material Removal
According to the social media company, the service has removed violative content and prohibited related hashtags and query recommendations. The organization said it was dedicated to maintaining the platform secure and investing in enhancing enforcement strategies.
Digital Marketplace Activities
Research also found groups with up to 9,000 participants selling the experimental drug using the platform's integrated discovery tool, which operates like a public directory. Entering “retatrutide” instantly displays groups with numerous of members, populated with images of slimming results, glowing testimonials and step-by-step instructions for mixing or administering at home.
Within minutes of entering one community, a vendor posted contact information, where most transactions take place. The seller provided an instruction manual and guaranteed shipping within 48 hours. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None inquired about weight, health issues or past usage.
Product Information and Costs
Within these groups, posts display black plastic parcels with postal service labels, stating to include new batches. One message stated: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, mixed at home with sterile water, or pre-filled pens usually priced at £160 for 20 milligrams. When asked how much time a injector should be used, sellers give conflicting answers ranging from a several days to “depends on your body”.
Platform Oversight and Security Actions
A representative for Telegram said it regularly moderated harmful content on its platform including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Warnings
“Individuals are administering substances they can’t verify. Even if the science behind this drug is valid, these online products may not contain what they claim,” said a pharmacy expert, the director of pharmacy at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to recent cost increases for authorized slimming medications such as Mounjaro. “With costs rising, patients are turning to social media. But fake treatments are extremely dangerous. You can’t be certain what’s inside or whether the environment they were made in was clean,” she said.
Her team has already seen patients harmed by self-injection from unverified sources. “We recognize the disappointment, but purchasing from Telegram or communication platforms is gambling with your well-being,” said the doctor. “These substances could be contaminated or incorrectly dosed.”
Manufacturer Position
A spokesperson from the pharmaceutical company said retatrutide was in third stage research studies and had not been evaluated or authorized by any regulatory agency globally. “Consequently at this time no one can sell [it] for personal consumption,” they said, noting that any item “misleadingly claiming itself as a company experimental product not yet authorized … may expose patients to possibly serious health risks”.
